Category Archives: HIV cure advocacy

Project Inform: Transforming Hope into Reality

David Evans, Project Inform office circa 1993 When I started volunteering there in December 1992, Project Inform remained persistent in its message that you could take charge of your own health, all the while struggling against the pain of losing friends, lovers and family members to…Read More

HIV advocates publish HIV/AIDS Cure Research Glossary & Resource Guide

  To better inform journalists, service workers, advocates and people with HIV on the exciting and rapidly moving field of HIV cure research, advocates from the Delaney AIDS Research Enterprise (DARE), with assistance from advocates from the defeatHIV collaboratory and the Collaboratory of AIDS Researchers for…Read More

IAS2015: Teenager infected at birth controls HIV for 11 years without drugs

by David Evans, Director of Research Advocacy An HIV-positive teenager who started antiretroviral (ARV) drugs as an infant and stayed on them for about seven years, is now 18 years old and has been off of all medications for 11 years with very low levels of…Read More

CROI2015: New “Kick and Kill” HIV cure drug (TLR7 agonist) from Gilead shows promise

A new type of drug, called a toll-like receptor 7 (TLR7) agonist, was able to activate HIV-infected CD4 cells from HIV-positive donors on antiretroviral therapy (ART), leading to the release and replication of virus, according to a presentation at the 2015 Conference on Retroviruses and Opportunistic…Read More

Join us for a community forum on World AIDS Day

WORLD AIDS DAY FORUM: Getting to Zero in San Francisco … Progress and Plans Presented by the Getting to Zero Consortium* Monday, December 1, 2014, 6:30 to 8:30 pm San Francisco Department of Public Health 25 Van Ness Ave., 6th Floor The event is free and open to…Read More

NIH-led scientists discover HIV antibody that binds to novel target on virus

WHAT: An NIH-led team of scientists has discovered a new vulnerability in the armor of HIV that a vaccine, other preventive regimen or treatment could exploit. The site straddles two proteins, gp41 and gp120, that jut out of the virus and augments other known places where…Read More

AIDS2014: Cancer drug romidespin can kick HIV out of a dormant state

The cancer drug romidepsin was safe and effective at kicking HIV out of a dormant state in infected cells, according to researchers the 20th International AIDS Conference in Melbourne, Australia. A number of researchers are approaching a cure for HIV through what is known as a…Read More